Quarterly Result19 Mar 2026, 03:50 pm
Gaudium IVF Announces Q3 & 9M FY26 Financial Results, Raises ₹1,650.098 Crore in IPO
AI Summary
Gaudium IVF and Women Health Limited, a leading fertility and women’s healthcare platform in India, announced its unaudited financial results for the quarter and nine months ended December 31, 2025. The company reported strong financial performance and maintained healthy margins. The period also saw Gaudium IVF complete its Initial Public Offering (IPO), raising approximately ₹1,650.098 crore, and listing on the National Stock Exchange of India Limited and BSE Limited. The funds raised will strengthen the company's position as a differentiated, scaled platform in the fertility care segment.
Key Highlights
- Revenue from operations for Q3 FY26 stood at ₹2,450.70 lakh
- Profit before tax (PBT) for Q3 FY26 was ₹496.31 lakh
- Net profit for Q3 FY26 stood at ₹363.05 lakh
- Revenue from operations for 9M FY26 stood at ₹7,400.58 lakh
- Successfully raised approximately ₹1,650.098 crore in IPO